Skip to main content

Next Science (AU:NXS) — Company Overview, News & Financial Data

Next Science logo
NXSNext Science
Next Science primary media
Company profile

Next Science

About

Explore Australia companies

Next Science (ASX:NXS) is a medical technology company developing innovative solutions to help improve surgical outcomes and reduce surgical site infections. The company's primary focus is the development and continued commercialisation of its proprietary XBIO™ technology to reduce the impact of biofilm-based infections in human health.

Snapshot

Public AUOwnership
2012Year founded
102Employees
New South Wales, AustraliaHead office
Loading Map...
Global footprint

Operations

All Locations
Australia

Products and/or services of Next Science

  • XBIO™ technology: Next Science's flagship product is its XBIO™ technology, a platform technology that can be used to develop a range of products to treat and prevent biofilm-based infections.
  • XPERIENCE: Designed for use in cleansing and removal of debris, including microorganisms from wounds.
  • BLASTX: Antimicrobial Wound Gel provides wound management by maintaining a moist wound environment, which is conducive to wound healing. While in place, the antimicrobial properties of the gel inhibit the growth of microorganisms in the product.
  • SURGX: Sterile Antimicrobial Gel conforms to the postoperative wound. The gel provides a moist wound environment conducive to healing.
  • Bactisure: Wound Lavage is used to remove debris, including microorganisms, from wounds using pulsed lavage. It is a clear, colourless and low-odour solution.

Next Science executive team

  • Dr. Matthew Franco MynttiFounder & CTO
  • Mr. Jon SwansonChief Strategy Officer
  • Daniel CanonVice President of Operations
  • Francoise DixonHead of Investor Relations
  • Mr. Robert BellSenior Vice President of North American Sales
  • Ms. Gillian Maria Nairn AGIA, B.A., L.L.B., L.L.M., MAICDCompany Secretary